Bromontan, a new doping agent

  title={Bromontan, a new doping agent},
  author={Pascal Burnat and Alain Payen and Catherine Le Brumant-Payen and Michel Hugon and Franck Ceppa},
  journal={The Lancet},
The Probenecid-Story - a Success in the Fight against Doping through Out-of-Competition Testing.
The disclosure of the masking agent probenecid in 1987 is a perfect example for a memorable finding, suspected and purported case of performance manipulation.
Crystal structure of benzoato-κO-bis(1,3,5-triaza-7-phosphaadamantane-κP)silver(I) monohydrate C19H31AgN6O3P2
Abstract C19H31AgN6O3P2, monoclinic, P21/c (no. 14), a = 16.5661(8) Å, b = 6.1644(3) Å, c = 23.8822(10) Å, β = 114.553(3)°, V = 2218.32(18) Å3, Z = 4, Rgt(F) = 0.0188, wRref(F2) = 0.0525, T = 100(2)
Crystal structure of 1-(adamantan-1-yl)-3-(4-bromophenyl)thiourea, C17H21BrN2S
Abstract C17H21BrN2S, orthorhombic, Pbca (No. 61), a = 17.0675(7) Å, b = 8.3422(3) Å, c = 22.5970(8) Å, V = 3217.4(2) Å3, Z = 8, Rgt(F) = 0.0329, wRref(F2) = 0.0724, T = 100 K.
Crystal structure of 1-(adamantan-1-yl)-3-(3-chlorophenyl)thiourea, C17H21ClN2S
Abstract C17H21ClN2S, orthorhombic, Pca21 (no. 29), a = 25.4796(11) Å, b = 6.7503(3) Å, c = 18.9971(9) Å, V = 3267.4(3) Å3, Z = 8, Rgt(F) = 0.045, wRref(F2) = 0.106, T = 293(2).
Crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)thiourea, C17H21ClN2S
Abstract C17H21ClN2S, orthorhombic, Pbca (no. 61), a = 17.2134(6) Å, b = 8.2251(2) Å, c = 22.5220(7) Å, V = 3188.71(17) Å3, Z = 8, Rgt(F) = 0.0371, wRref(F2) = 0.0933, T = 100 K.
A Rapid and Sensitive LC-MS/MS Assay for the Quantitation of Bromantane in Human Plasma
The purpose of this study was to develop and validate a high-performance liquid chromatographic–tandem mass spectrometric (LC–MS/MS) method for analysis of the bromantane in human plasma. The analyte
Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
The new analytical progresses, technologies and knowledge used by the Olympic laboratories, which for the vast majority of them are, eventually, incorporated into routine anti-doping analysis are summarized.
The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance
The history of actoprotectors’ development, their pharmacological properties, mechanism of action, and practical application to the improvement of mental and physical performance are explored.
History of doping and doping control.
The expression “dope” was introduced into English Turf Sport about 1900 for illegal drugging of racehorses and was extended in a broader sense to other beverages with stimulating properties.
History of mass spectrometry at the Olympic Games.
An overview of how doping analysis has developed and where it is today gives an overview of the joint endeavours of the World Anti-Doping Agency, the International Olympic Committee, the international federations and national anti-doping agencies.